4
Changes in Ownership
PROTHENA CORP PUBLIC LTD CO Filed Acc 0001140361-22-039910
Chief Medical Officer sold 4,000 shares at an average $61.89 ($247,575)
- Chief Medical Officer acquired 4,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Garren Hideki Chief Medical Officer | 2022-11-01 | Option exercise | +4,000 | $24.90 | $99,600 | 4,000 | D |
| Garren Hideki Chief Medical Officer | 2022-11-01 | Sale | −3,489 | $61.82 | $215,683 | 511 | D |
| Garren Hideki Chief Medical Officer | 2022-11-01 | Sale | −511 | $62.41 | $31,892 | 0 | D |
| Derivatives | |||||||
| Garren Hideki Chief Medical Officer | 2022-11-01 | Option exercise · Stock Option (Right to Buy) | −4,000 | 226,000 | D | ||
| Open-market sales · 4,000 sh · avg $61.89 · $247,575 | |||||||
Loading xslF345X03/form4.xml…